Drug Type Recombinant protein |
Synonyms GSI-1901 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Globin Solutions, Inc.Startup |
Active Organization- |
Inactive Organization Globin Solutions, Inc.Startup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Carbon Monoxide Poisoning | Preclinical | US | Globin Solutions, Inc.Startup | 17 Nov 2021 |